![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, October 15, 2018 2:37:01 PM
"We have acted as outside counsel to Immune Therapeutics, Inc., a Florida corporation (the “Company “), in connection with the preparation of the Company’s Registration Statement on Form S-8, (the “Registration Statement “) with respect to the registration under the Securities Act of 1933, as amended (the “Securities Act “), of 3,000,000 shares (“Registered Shares “) of the Company’s common stock, par value $0.0001 per share (the “Common Stock “), which may be issued upon the terms and subject to the conditions set forth in the Independent Corporate Development and Legal Advising Agreement, executed December 6, 2017, between the Company and, inter alia, Chad S. Johnson (the “Agreement”)."
Chad S Johnson??? Hmmmmmmmm
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM